PharmaResources (Shanghai) Co., Ltd

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 1.96% vs 29.57% in Mar 2025",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is 98.33% vs 224.32% in Mar 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "172.00",
          "val2": "168.70",
          "chgp": "1.96%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "11.40",
          "val2": "32.50",
          "chgp": "-64.92%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.90",
          "val2": "2.20",
          "chgp": "-13.64%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "11.50",
          "val2": "1.80",
          "chgp": "538.89%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "23.80",
          "val2": "12.00",
          "chgp": "98.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.30%",
          "val2": "53.80%",
          "chgp": "1.25%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is 26.70% vs 11.10% in Dec 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is 100.58% vs -54.52% in Dec 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "687.60",
          "val2": "542.70",
          "chgp": "26.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "117.70",
          "val2": "69.20",
          "chgp": "70.09%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "8.50",
          "val2": "9.50",
          "chgp": "-10.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "7.00",
          "val2": "5.10",
          "chgp": "37.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "34.30",
          "val2": "17.10",
          "chgp": "100.58%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "33.80%",
          "val2": "-15.50%",
          "chgp": "4.93%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

172.00

168.70

1.96%

Operating Profit (PBDIT) excl Other Income

11.40

32.50

-64.92%

Interest

1.90

2.20

-13.64%

Exceptional Items

11.50

1.80

538.89%

Consolidate Net Profit

23.80

12.00

98.33%

Operating Profit Margin (Excl OI)

66.30%

53.80%

1.25%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is 1.96% vs 29.57% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is 98.33% vs 224.32% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

687.60

542.70

26.70%

Operating Profit (PBDIT) excl Other Income

117.70

69.20

70.09%

Interest

8.50

9.50

-10.53%

Exceptional Items

7.00

5.10

37.25%

Consolidate Net Profit

34.30

17.10

100.58%

Operating Profit Margin (Excl OI)

33.80%

-15.50%

4.93%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is 26.70% vs 11.10% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is 100.58% vs -54.52% in Dec 2024

All Annual Results